Ischemic stroke at a young age and thrombophilia caused by deficiency or abnormality of physiological anticoagulants
- Authors: Pizova N.V1
-
Affiliations:
- Yaroslavl State Medical University of the Ministry of Health of the Russian Federation
- Issue: Vol 17, No 9 (2015)
- Pages: 21-26
- Section: Articles
- URL: https://ogarev-online.ru/2075-1753/article/view/94322
- ID: 94322
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
N. V Pizova
Yaroslavl State Medical University of the Ministry of Health of the Russian Federation
Email: pizova@yndex.ru
д-р мед. наук, проф. каф. нервных болезней с медицинской генетикой и нейрохирургией ГБОУ ВПО ЯГМУ 150000, Russian Federation, Yaroslavl, ul. Revoliutsionnaia, d. 5
References
- Franchini M, Veneri D. Inherited thrombophilia: an update. Clin Lab 2005; 51: 357-65.
- Nachman R.L, Silverstein R. Hypercoagulable states. Ann Intern Med 1993; 119: 819-7.
- Schafer A.I. The hypercoagulable states. Ann Intern Med 1985; 102: 814-28.
- Jordan F.L.J, Nandorff A. The familial tendency in thromboembolic disease. Acta Med Scand 1956; 156: 267-75.
- Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thromb Diath Haemorgh 1965; 13: 516-30.
- Egeberg O. Proceedings: Inherited antithrombin III deficiency and thromboembolism. Thromb Diath Haemorgh 1975; 34: 366.
- Manucci P.M. The molecular basis of inherited thrombophilia. Vox Sang 2000; 78: 39-5.
- Сушкевич Г.Н. Тромбогенерирующие системы при тромбофилиях различного генеза. Лаб. мед. 2009; 10: 11-22.
- Патрушев Л.И. Тромбофилические состояния и современные методы их диагностики. РМЖ. 1998; 6 (3): 181-5.
- Васильев С.А., Виноградов В.Л., Гемджян Э.Г. и др. Сочетанные генетические и приобретенные формы тромбофилий. 4-я Всерос. конф. «Клиническая гемостазиология в сердечно - сосудистой хирургии» (с международным участием). М.: НЦССХ им. А.Н.Бакулева, 2009; с. 84-5.
- Barinagarrementeria F, Cantu-Brito C, De La Pena A, Izaguirre R. Prothrombotic states in young people with idiopathic stroke. A prospective study. Stroke 1994; 25 (2): 287-90.
- Bock S, Harris J, Balazs I, Trent J. Assignment of the human antithrombin III structural gene to chromosome 1q23-25. Cytogenet Cell Genet 1985; 39: 67-9.
- Kobelt K, Biasiutti F.D, Mattle H.P et al. Protein Z in ischaemic stroke. Br J Haematol 2001; 114: 169-73.
- Spek C.A, Reitsma P.H. Genetic risk factors for venous thrombosis. Mol Genet Metab 2000; 71: 51-61.
- Lane D.A, Olds R.J, Boisclair M et al. Antithrombin III mutation database: first update. For the Thrombin and its Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1993; 70 (2): 361-9.
- Lane D, Bayston T, Olds R et al. Antithrombin mutation database: 2nd (1997) update. For the Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1997; 77: 197-211.
- Лагутина Н.Я., Федулова Г.А. Антитромбин III. Обзор. Пробл. гематологии. 1982; 3: 42-50.
- Thaler E, Lechner K. Antithrombin III deficiency and thromboembolism. Clin Haematol 1981; 10 (2): 369-90.
- Martinelli I, Mannucci P.M, De Stefano V et al. Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families. Blood 1998; 92 (7): 2353-8.
- Simioni P, Sanson B.J, Prandoni P et al. Incidence of venous thromboembolism in families with inherited thrombophilia. Thromb Haemost 1999; 81 (2): 198-202.
- Tait R.C, Walker I.D, Perry D.J et al. Prevalence of antithrombin deficiency in the healthy population. Br J Haematol 1994; 87 (1): 106-12.
- Moster M. Coagulopathies and arterial stroke. J Neuro-Ophthalmol 2003; 23 (1): 63-71.
- Tollefsen D.M, Majerus D.W, Blank M.K. Heparin cofactor II. Purification and properties of a heparin - dependent inhibitor of thrombin in human plasma. J Biol Chem 1982; 257 (5): 2162-9.
- Tollefsen D.M. Heparin cofactor II modulates the response to vascular injury. Arterioscler Thromb Vasc Biol 2007; 27: 454-60.
- Tollefsen D.M. Heparin cofactor II deficiency. Arch Pathol Lab Med 2002; 126: 1394-400.
- Schwarz H.P, Fischer M, Hopmeier P et al. Plasma protein S deficiency in familial thrombotic disease. Blood 1984; 64 (6): 1297-300.
- Tran T.H, Duckert F. Influence of heparin cofactor II (HCII) on the determination of antithrombin III (AT). Thromb Res. 1985; 40 (4): 571-6.
- Huntington J.A, Kjellberg M, Stenflo J. Crystal structure of protein C inhibitor provides insights into hormone binding and heparin activation. Structure 2003; 11: 205-15.
- Dhainaut J-F, Yan В, Cariou A, Mira J-P. Soluble thrombomodulin, plasma - derived unactivated protein C, and recombinant human activated protein С in sepsis. Crit Care Med 2002; 30: 318-24.
- Esmon C. The protein С pathway. Crit Care Med 2000; 28: 44-8.
- Pike R.N, Buckle A.M, le Bonniec B.F, Church F.C. Control of the coagulation system by serpins. Getting by with a little help from glycosaminoglycans. FEBS J 2005; 272: 4842-51.
- Aznar J, Espana F, Estelles A, Royo M. Heparin stimulation of the inhibition of activated protein C and other enzymes by human protein C inhibitor - influence of the molecular weight of heparin and ionic strength. Thromb Haemost 1996; 76: 983-8.
- Dahlback B, Carlsson M, Svensson P.J. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90 (3): 1004-8.
- Bertina R.M, Broekmans A.W, van der Linden I.K, Mertens K. Protein C deficiency in a Dutch family with thrombotic disease. Thromb Haemost 1982; 48 (1): 1-5.
- Bertina R.M, Broekmans A.W, Krommenhoek van Es C, van Wijngaarden A. The use of a functional and immunologic assay for plasma protein C in the study of the heterogeneity of congenital protein C deficiency. Thromb Haemost 1984; 51 (1): 1-5.
- Comp P.C, Nixon R.R, Esmon C.T. Determination of functional levels of protein C, an antithrombotic protein, using thrombin - thrombomodulin complex. Blood 1984; 63 (1): 15-21.
- Comp P.C, Esman C.T. Recurrent venous thromboembolism in patients with a partial deficiency of protein C. N Engl J Med 1984; 311 (24): 1525-28.
- Patracchini P, Aiello V, Palazzi P et al. Sublocalization of the human protein C gene on chromosome 2q13-q14. Hum Genet 1989; 81 (2): 191-2.
- De Stefano V, Rossi E, Paciaroni K, Leone G. Screening for inherited thrombophilia: indications and therapeutic implications. Haematologica 2002; 87: 1095-108.
- Griffin J.H, Evatt B, Zimmermann T.S et al. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 1981; 68: 1370-73.
- Pabinger J, Kurie P.A, Heistinger M et al. The risc of thromboembolism in asymptomatic patients with protein C and protein S debiciencg. Thromb Haemost 1994; 71: 441-5.
- Miletich J.P, Sherman L, Broze G.J.J. Absence of thrombosis in subjects with heterozygous protein C deficiency. N Engl J Med 1987; 317: 991-6.
- Griffin J.H. Clinical studies of protein C. Semin Thromb Hemost 1984; 10 (2): 162-6.
- Tait R.C, Walker I.D, Reitsma P.H et al. Prevalence of protein C deficiency in the healthy population. Thromb Haemost 1995; 73 (1): 87-93.
- Meijer-Huizinga F, Mertens K, van Mourik J.A. Isolation and characterization of single - chain protein S. Thromb Haemost 1994; 72 (3): 408-14.
- Walker F.J. Regulation of activated protein C by a new protein. A possible function for bovine protein S. J Biol Chem 1980; 255 (12): 5521-4.
- Walker F.J. Regulation of activated protein C by protein S. The role of phospholipid in factor Va inactivation. J Biol Chem 1981; 256 (21): 11128-31.
- Walker F.J, Chavin S.I, Fay P.J. Inactivation of factor VIII by activated protein C and protein S. Arch Biochem Biophys 1987; 252 (1): 322-8.
- Schwarz H.P, Fischer M, Hopmeier P et al. Plasma protein S deficiency in familial thrombotic disease. Blood 1984; 64 (6): 1297-300.
- Allaart C.F, Aronson D.C, Ruys T et al. Hereditary protein S deficiency in young adults with arterial occlusive disease. Thromb Haemost 1990; 64 (2): 206-10.
- Broekmans A.W, Bertina R.M, Reinalda-Poot J et al. Hereditary protein S deficiency and venous thrombo - embolism. A study in three Dutch families. Thromb Haemost 1985; 53 (2): 273-7.
- Makris M, Leach M, Beauchamp N.J et al. Genetic analysis, phenotypic diagnosis, and risk of venous thrombosis in families with inherited deficiencies of protein S. Blood 2000; 95 (6): 1935-41.
- Long G.L, Marshall A, Gardner J.C, Naylor S.L. Genes for human vitamin K-dependent plasma proteins C and S are located on chromosomes 2 and 3, respectively. Somat Cell Mol Genet 1988; 14 (1): 93-8.
- Watkins P.C, Eddy R, Beck A.K et al. DNA sequence and regional assignment of the human follicle - stimulating hormone beta - subunit gene to the short arm of human chromosome 11. DNA 1987; 6 (3): 205-12.
- Watkins P.C, Eddy R, Fukushima Y et al. The gene for protein S maps near the centromere of human chromosome 3. Blood 1988; 71 (1): 238-41.
- Engesser L, Broekmans A.W, Briet E et al. Hereditary protein S deficiency: clinical manifestations. Ann Intern Med 1987; 106 (5): 677-82.
- Girolami A, Simioni P, Lazzaro A.R, Cordiano I. Severe arterial cerebral thrombosis in a patient with protein S deficiency (moderately reduced total and markedly reduced free protein S): a family study. Thromb Haemost 1989; 61 (1): 144-7.
- Sie P, Boneu B, Bierme R et al. Arterial thrombosis and protein S deficiency. Thromb Haemost 1989; 62 (3): 1040.
- Wiesel M.L, Borg J.Y, Grunebaum L et al. Influence of protein S deficiency on the arterial thrombosis risk. Presse Med 1991; 20 (22): 1023-7.
- Douay X, Lucas C, Caron C et al. Antithrombin, protein C and protein S levels in 127 consecutive young adults with ischemic stroke. Acta Neurol Scand 1998; 98 (2): 124-7.
- Mayer S.A, Sacco R.L, Hurlet-Jensen A et al. Free protein S deficiency in acute ischemic stroke. A case - control study. Stroke 1993; 24 (2): 224-7.
- Broze G.J, Miletich J.P. Human protein Z. J Clin Invest 1984; 73: 933-38.
- Hogg P.J, Stenflo J. Interaction of vitamin K-dependent protein Z with thrombin. J Biol Chem 1990; 266: 1053-58.
- Hogg P.J, Stenflo J. Interaction of human protein Z with thrombin: evaluation of the species difference in the interaction between bovine and human protein Z and thrombin. Biochem Biophys Res Commun 1991; 178: 801-7.
- Kempkes-Matthes B, Walmrath D, Matthes K.J. Protein Z deficiency: a new cause of bleeding tendency. Thromb Res 1995; 79: 49-55.
- Broze G.J.Jr. Protein Z dependent regulation of coagulation. Thromb Haemost 2001; 86: 8-13.
- Kemkes-Matthes B, Souri M, Ichinose A, Matthes K.J. First cases of homozygous combined protein Z- and factor V Leiden - mutation in humans. Blood 2000; 96: 74b. Abstract.
- Kemkes-Matthes B, Nees M, Kuhnel G et al. Protein Z influences prothrombotic phenotype of factor V Leiden in humans. Thromb Res 2002; 106: 183-85.
- Mc Quillan A.M, Eikelboom J.W, Hankey G.J et al. Protein Z in ischemic stroke and its etiologic subtypes. Stroke 2003; 34: 2415-19.
- Fujimaki K, Yamazaki T, Taniwaki M, Ichinose A. The gene for human protein Z is localized to chromosome 13 at band q34 and is coded by eight regular exons and one alternative exon. Biochemistry 1998; 37: 6838-46.
- Vasse M, Guegan-Massardier E, Borg J.Y et al. Frequency of protein Z deficiency in patients with ischaemic stroke. Lancet 2001; 357: 933-34.
- Heeb M.J, Paganini-Hill A, Griffin J.H, Fischer M. Low protein Z levels and risk of ischaemic stroke: differences by diabetic status and gender. Blood Cells Mol Dis 2002; 29: 139-44.
- Lopaciuk S, Bykowska K, Kwiecinski H et al. Protein Z in young survivors of ischaemic stroke. Thromb Haemost 2002; 88: 536.
- Личи К, Кропп С, Донг-Си Т и др. Уровень протеина Z в плазме и риск развития ишемии головного мозга у молодых лиц зависят от варианта полиморфизма гена, кодирующего этот белок. Stroke. Российское издание. 2004; 5: 64-70.
- Bird P. Thrombomodulin. Haematol Rev 1996; 9: 251-74.
- Кудряшева О.В., Затейщиков Д.А., Сидоренко Б.А. Эндотелиальный гемостаз: система тромбомодулина и ее роль в развитии атеросклероза и его осложнений. Кардиология. 2000; 40 (8): 65-70.
- Bushnell C.D, Goldstein L.B. Diagnostic testing for coagulopathies in patients with ischemic stroke. Stroke 2000; 31: 3067-78.
- Carod-Artal F.J, Nunes S.V, Portugal D et al. Ischemic stroke subtypes and thrombophilia in young and elderly Brazilian stroke patients admitted to a rehabilitation hospital. Stroke 2005; 36 (9): 2012-4.
- Ranzan J, Rotta N.T. Ischemic stroke in children: a study of the associated alterations. Arq Neuropsiquiatr 2004; 62 (3A): 618-25.
- Hellgren M, Svensson P.J, Dahlback B. Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and contraceptives. Am J Obstet Gynecol 1995; 173: 210-13.
- Gandrille S, Greengard J.S, Alhenc-Gelas M et al. Incidence of activated protein C resistance caused by the ARG 506 GLN mutation in factor V in 113 unrelated symptomatic protein C-deficient patients. The French Network on the behalf of INSERM. Blood 1995; 86: 219-24.
- Zoller B, Berntsdotter A, Garcia de Frutos P, Dahlback B. Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S. Blood 1995; 85: 3518-23.
- Alhenc-Gelas M, Aiach M, de Moerloose P. Venous thromboembolic disease: risk factors and laboratory investigation. Semin Vasc Med 2001; 1 (1): 81-8.
- Varnai K, Gutler F, Szekely E. Hemorheological parameters in patients with thrombophilia. Biorheology 1999; 1-2: 148.
Supplementary files
